Maha Al‐Amri

416 total citations
22 papers, 303 citations indexed

About

Maha Al‐Amri is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Maha Al‐Amri has authored 22 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Maha Al‐Amri's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Maha Al‐Amri is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Maha Al‐Amri collaborates with scholars based in Saudi Arabia, United States and Qatar. Maha Al‐Amri's co-authors include Allan D. Sniderman, Katherine Cianflone, Jessica Smith, Dorairaj Prabhakaran, Edward N. Mercer, Reem S. Almaghrabi, Bruce E. Dunn, Sahar Althawadi, Walter Conca and Futwan Al‐Mohanna and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Maha Al‐Amri

20 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maha Al‐Amri Saudi Arabia 9 157 93 79 56 45 22 303
A. Kopp Germany 10 173 1.1× 70 0.8× 35 0.4× 17 0.3× 14 0.3× 14 311
Bahareh Sedaghati-khayat Iran 14 55 0.4× 82 0.9× 55 0.7× 113 2.0× 20 0.4× 34 421
Tobias Niedrist Austria 12 131 0.8× 71 0.8× 25 0.3× 51 0.9× 7 0.2× 34 424
Hongjie Hou China 11 43 0.3× 55 0.6× 31 0.4× 26 0.5× 17 0.4× 17 267
Mumtaz Ahmad Pakistan 10 53 0.3× 87 0.9× 15 0.2× 39 0.7× 35 0.8× 28 351
Shiyun Luo China 7 68 0.4× 145 1.6× 22 0.3× 52 0.9× 27 0.6× 10 287
Hiromichi Imaizumi Japan 9 156 1.0× 53 0.6× 8 0.1× 55 1.0× 14 0.3× 21 298
É Baranyi Hungary 8 114 0.7× 77 0.8× 12 0.2× 42 0.8× 57 1.3× 16 406
A. Kallitsaris Greece 14 81 0.5× 60 0.6× 21 0.3× 54 1.0× 89 2.0× 29 457
Pahnwat Taweesedt United States 9 109 0.7× 42 0.5× 10 0.1× 18 0.3× 15 0.3× 34 349

Countries citing papers authored by Maha Al‐Amri

Since Specialization
Citations

This map shows the geographic impact of Maha Al‐Amri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Al‐Amri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Al‐Amri more than expected).

Fields of papers citing papers by Maha Al‐Amri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha Al‐Amri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Al‐Amri. The network helps show where Maha Al‐Amri may publish in the future.

Co-authorship network of co-authors of Maha Al‐Amri

This figure shows the co-authorship network connecting the top 25 collaborators of Maha Al‐Amri. A scholar is included among the top collaborators of Maha Al‐Amri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha Al‐Amri. Maha Al‐Amri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kaddoura, Rasha, et al.. (2024). COVID-19-associated hypertriglyceridemia and impact of treatment. Frontiers in Medicine. 11. 1326156–1326156. 2 indexed citations
3.
Al‐Amri, Maha, et al.. (2024). Early predictors of intensive care unit admission among COVID-19 patients in Qatar. Frontiers in Public Health. 12. 1278046–1278046. 2 indexed citations
4.
5.
Al‐Amri, Maha, et al.. (2023). Update on Covid-19: vaccines, timing of transplant after COVID-19 infection and use of positive donors. Current Opinion in Organ Transplantation. 28(2). 76–84. 2 indexed citations
6.
Al‐Amri, Maha, et al.. (2022). Characteristics and Early Predictors of Intensive Care Unit Admission among COVID-19 Patients in Qatar. International Journal of Infectious Diseases. 116. S26–S26. 1 indexed citations
7.
Al‐Amri, Maha, Sahar Althawadi, Fahad Al-Ajlan, et al.. (2021). Invasive fungal infection of the brain caused by Neoscytalidium dimidiatum in a post-renal transplant patient: A case report. Medical Mycology Case Reports. 34. 27–31. 7 indexed citations
8.
Almaghrabi, Reem S., Fatimah S. Alhamlan, Ashraf Dada, et al.. (2021). Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients. Journal of Infection and Public Health. 15(1). 51–55. 6 indexed citations
9.
Al‐Amri, Maha, et al.. (2021). Disseminated histoplasmosis in a heart transplant recipient from Saudi Arabia: A case report. Journal of Infection and Public Health. 14(8). 1013–1017. 6 indexed citations
10.
Conca, Walter, Michael Foster, Maha Al‐Amri, et al.. (2021). Serum β2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity?. PLoS ONE. 16(3). e0247758–e0247758. 14 indexed citations
11.
Zowawi, Hosam M., Thamer H. Alenazi, Omar Aldibasi, et al.. (2021). Portable RT-PCR System: a Rapid and Scalable Diagnostic Tool for COVID-19 Testing. Journal of Clinical Microbiology. 59(5). 16 indexed citations
12.
Vriz, Olga, et al.. (2021). Left atrial strain can predict right ventricular impairment and developement of atrial fibrilation in patients with severe mitral stenosis better than transmitral gradients. European Heart Journal - Cardiovascular Imaging. 22(Supplement_1). 2 indexed citations
13.
Mahfouz, Ahmed, et al.. (2020). Impact of discharge education by clinical pharmacists on patients' adherence to post‐percutaneous coronary intervention medications: A retrospective cohort study using real‐world data. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4(3). 303–310. 2 indexed citations
14.
Mahfouz, Ahmed, et al.. (2020). Medications adherence post‐primary percutaneous coronary intervention in acute myocardial infarction: A population‐based cohort study. Journal of Clinical Pharmacy and Therapeutics. 46(3). 772–779. 9 indexed citations
15.
Al‐Amri, Maha, et al.. (2016). Progressive coronary aneurysms in Behçet disease, a journey through surgical and percutaneous treatment: A case report. Journal of Cardiology Cases. 14(1). 32–34. 1 indexed citations
16.
Smith, Jessica, Maha Al‐Amri, Allan D. Sniderman, & Katherine Cianflone. (2006). Visfatin concentration in Asian Indians is correlated with high density lipoprotein cholesterol and apolipoprotein A1. Clinical Endocrinology. 65(5). 667–672. 29 indexed citations
17.
Smith, Jessica, Maha Al‐Amri, Allan D. Sniderman, & Katherine Cianflone. (2006). Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women. Nutrition & Metabolism. 3(1). 18–18. 75 indexed citations
18.
Cianflone, Katherine, et al.. (2006). Body composition and the apoB/apoA-I ratio in migrant Asian Indians and white Caucasians in Canada. Clinical Science. 111(3). 201–207. 19 indexed citations
19.
Al‐Amri, Maha, et al.. (2005). The adipocyte life cycle hypothesis. Clinical Science. 110(1). 1–9. 73 indexed citations
20.
Mercer, Edward N., et al.. (1989). Doppler echocardiography in the evaluation of tricuspid stenosis. European Heart Journal. 10(11). 985–990. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Kopp Breakdown of academic impact, for papers by Bahareh Sedaghati-khayat Breakdown of academic impact, for papers by Tobias Niedrist Breakdown of academic impact, for papers by Hongjie Hou Breakdown of academic impact, for papers by Mumtaz Ahmad Breakdown of academic impact, for papers by Shiyun Luo Breakdown of academic impact, for papers by Hiromichi Imaizumi Breakdown of academic impact, for papers by É Baranyi Breakdown of academic impact, for papers by A. Kallitsaris Breakdown of academic impact, for papers by Pahnwat Taweesedt
Rankless by CCL
2026